212 related articles for article (PubMed ID: 26066075)
41. Identification of corticosteroid-regulated genes in cardiomyocytes by serial analysis of gene expression.
Muller O; Pradervand S; Berger S; Centeno G; Milet A; Nicod P; Pedrazzini T; Tronche F; Schütz G; Chien K; Rossier BC; Firsov D
Genomics; 2007 Mar; 89(3):370-7. PubMed ID: 17174066
[TBL] [Abstract][Full Text] [Related]
42. Nontraditional aspects of aldosterone physiology.
Ngarmukos C; Grekin RJ
Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1122-7. PubMed ID: 11701424
[TBL] [Abstract][Full Text] [Related]
43. Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation.
Faresse N; Vitagliano JJ; Staub O
FASEB J; 2012 Oct; 26(10):4373-82. PubMed ID: 22798426
[TBL] [Abstract][Full Text] [Related]
44. Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel.
Ziera T; Irlbacher H; Fromm A; Latouche C; Krug SM; Fromm M; Jaisser F; Borden SA
FASEB J; 2009 Nov; 23(11):3936-46. PubMed ID: 19567370
[TBL] [Abstract][Full Text] [Related]
45. The nongenomic actions of aldosterone.
Funder JW
Endocr Rev; 2005 May; 26(3):313-21. PubMed ID: 15814845
[TBL] [Abstract][Full Text] [Related]
46. Mineralocorticoid receptor knockout mice: lessons on Na+ metabolism.
Berger S; Bleich M; Schmid W; Greger R; Schütz G
Kidney Int; 2000 Apr; 57(4):1295-8. PubMed ID: 10760057
[TBL] [Abstract][Full Text] [Related]
47. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
[TBL] [Abstract][Full Text] [Related]
48. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
[TBL] [Abstract][Full Text] [Related]
49. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter.
Grossmann C; Krug AW; Freudinger R; Mildenberger S; Voelker K; Gekle M
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1790-800. PubMed ID: 17311890
[TBL] [Abstract][Full Text] [Related]
50. Genome-wide analysis of murine renal distal convoluted tubular cells for the target genes of mineralocorticoid receptor.
Ueda K; Fujiki K; Shirahige K; Gomez-Sanchez CE; Fujita T; Nangaku M; Nagase M
Biochem Biophys Res Commun; 2014 Feb; 445(1):132-7. PubMed ID: 24491541
[TBL] [Abstract][Full Text] [Related]
51. USP2-45 represses aldosterone mediated responses by decreasing mineralocorticoid receptor availability.
Faresse N; Debonneville A; Staub O
Cell Physiol Biochem; 2013; 31(2-3):462-72. PubMed ID: 23548632
[TBL] [Abstract][Full Text] [Related]
52. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
[TBL] [Abstract][Full Text] [Related]
53. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors.
Rogerson FM; Yao YZ; Elsass RE; Dimopoulos N; Smith BJ; Fuller PJ
Mol Endocrinol; 2007 Apr; 21(4):817-28. PubMed ID: 17284665
[TBL] [Abstract][Full Text] [Related]
54. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues revisited.
Morris DJ; Latif SA; Brem AS
Steroids; 2009 Jan; 74(1):1-6. PubMed ID: 19013186
[TBL] [Abstract][Full Text] [Related]
55. Aldosterone resistance: structural and functional considerations and new perspectives.
Zennaro MC; Hubert EL; Fernandes-Rosa FL
Mol Cell Endocrinol; 2012 Mar; 350(2):206-15. PubMed ID: 21664233
[TBL] [Abstract][Full Text] [Related]
56. Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.
Fuller PJ; Yao YZ; Jin R; He S; Martín-Fernández B; Young MJ; Smith BJ
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18578-18583. PubMed ID: 31439819
[TBL] [Abstract][Full Text] [Related]
57. Regulation of epithelial ion transport by aldosterone through changes in gene expression.
Bhargava A; Wang J; Pearce D
Mol Cell Endocrinol; 2004 Mar; 217(1-2):189-96. PubMed ID: 15134817
[TBL] [Abstract][Full Text] [Related]
58. The epithelial sodium channel (ENaC): Mediator of the aldosterone response in the vascular endothelium?
Kusche-Vihrog K; Callies C; Fels J; Oberleithner H
Steroids; 2010; 75(8-9):544-9. PubMed ID: 19778545
[TBL] [Abstract][Full Text] [Related]
59. A colonic mineralocorticoid receptor cell model expressing epithelial Na+ channels.
Bergann T; Plöger S; Fromm A; Zeissig S; Borden SA; Fromm M; Schulzke JD
Biochem Biophys Res Commun; 2009 May; 382(2):280-5. PubMed ID: 19275887
[TBL] [Abstract][Full Text] [Related]
60. Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone.
Yokota K; Shibata H; Kobayashi S; Suda N; Murai A; Kurihara I; Saito I; Saruta T
Endocr Res; 2004 Nov; 30(4):611-6. PubMed ID: 15666800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
